This study is completed in the United States. It is testing Effects of Oral NMRA-335140 for depression.
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Then choose your country and confirm availability with each study site.
In plain English
Key information made simple
What is this study testing?
This study is testing whether NMRA-335140 80 mg may be useful for adults experiencing bipolarity.
What would participation involve?
Participants may receive NMRA-335140 80 mg, attend study visits with the research team. The protocol may also involve randomization, placebo, or a comparison group. The registry lists locations in the United States.
Who is it mainly for?
This study appears to be mainly for adults with bipolarity.
What should you check before joining?
Ask about the dose, safety monitoring, and possible side effects, whether there is placebo, randomization, or a comparison group, how many visits or travel steps are needed, the exact eligibility criteria.
Your next step
Check the study details
Check the official source, then confirm these points with the research team.
Where are visits, can any be remote, and how much time is needed?
Costs and support
What costs, reimbursement or compensation apply?
Before joining
Questions to ask before joining
What are the exact eligibility criteria, and what could exclude someone?
How many visits, assessments, or follow-ups are expected, and over what period?
What risks, side effects, practical burdens, or alternatives should be understood first?
Who should be contacted to confirm locations, timing, compensation, and next steps?
Study clarity
Things to check before joining
Study start dateStarted: May 13, 2024
Recruitment status
Completed
Enrollment listed in the registry
18
Sponsor
Neumora Therapeutics, Inc.
Sponsor type
Biotech company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 65 Years
Official registry ID
NCT06429722
Official title
A Phase 2a, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With a Major Depressive Episode Associated With Bipolar II Disorder
Ask HopeStage to help me review this study
This record does not confirm open recruitment. We can help you understand it and explore other studies.
Study ID: NCT06429722. We help you review the study, but cannot decide medical eligibility.
Check recruitment and locations
Recruitment checked against the registry by HopeStage on . Registry information can change. Always confirm availability with the research team.
The overall study status can differ from each site's status. Open a country to see its locations and their registry status.
United States · 21 sites
Neumora Investigator Site
Phoenix, Arizona
Site status: Not listed — confirm with the team
Neumora Investigator Site
Little Rock, Arkansas
Site status: Not listed — confirm with the team
Neumora Investigator Site
Garden Grove, California
Site status: Not listed — confirm with the team
Neumora Investigator Site
Long Beach, California
Site status: Not listed — confirm with the team
Neumora Investigator Site
San Jose, California
Site status: Not listed — confirm with the team
Neumora Investigator Site
Torrance, California
Site status: Not listed — confirm with the team
Neumora Investigator Site
Gainesville, Florida
Site status: Not listed — confirm with the team
Neumora Investigator Site
Lauderhill, Florida
Site status: Not listed — confirm with the team
Neumora Investigator Site
Maitland, Florida
Site status: Not listed — confirm with the team
Neumora Investigator Site
Miami, Florida
Site status: Not listed — confirm with the team
Neumora Investigator Site
Miami Lakes, Florida
Site status: Not listed — confirm with the team
Neumora Investigator Site
Marietta, Georgia
Site status: Not listed — confirm with the team
Neumora Investigator Site
Savannah, Georgia
Site status: Not listed — confirm with the team
Neumora Investigator Site
Watertown, Massachusetts
Site status: Not listed — confirm with the team
Neumora Investigator Site
Flowood, Mississippi
Site status: Not listed — confirm with the team
Neumora Investigator Site
Marlton, New Jersey
Site status: Not listed — confirm with the team
Neumora Investigator Site
Princeton, New Jersey
Site status: Not listed — confirm with the team
Neumora Investigator Site
Toms River, New Jersey
Site status: Not listed — confirm with the team
Neumora Investigator Site
Brooklyn, New York
Site status: Not listed — confirm with the team
Neumora Investigator Site
Houston, Texas
Site status: Not listed — confirm with the team
Neumora Investigator Site
Bellevue, Washington
Site status: Not listed — confirm with the team
In practice
For you
Participation may contribute to research. Personal benefit is not guaranteed.
Ask the research team to explain the activities, time commitment, and follow-up involved.
Study sites are listed. Confirm the relevant site and any travel before making plans.
Important
Not medical advice
Information from public sources.
Are you the study sponsor? Contact us to update this page: hi@hopestage.com
FAQ
Questions about this study
What is this study trying to understand?
This study is exploring medication or study treatment for people with bipolarity. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed. The detailed objective is not always clearly listed in the public registry; the study team can confirm.
Does this study involve a medication?
This appears to be a medication / drug study involving NMRA-335140 80 mg, Placebo. Phase 2 studies usually explore whether the intervention may work, while continuing to monitor safety.
Who might this study be for?
This study may concern people with bipolarity; age range: From 18 Years to 65 Years. The criteria appear fairly specific, but you should not assume you are eligible. The study team must confirm diagnosis, age, exclusions, available locations, and next steps.
What would I likely need to do?
You may need to take a study treatment and have regular medical follow-up. The listed study locations suggest that at least part of participation may involve a physical site. Ask whether some steps can be done remotely.
What side effects, interactions, or treatment changes should I check?
If the study involves a medication, ask whether it is already approved, experimental, or being tested for a new use. Check possible side effects, interactions with current treatment, dose changes, monitoring, and what happens if you feel worse. For any mental health study, also ask who to contact if you feel worse, whether participation may affect current treatment, whether you can stop, and who confirms eligibility.
Will I need to travel or attend in-person visits?
The listed study locations suggest that at least part of participation may involve a physical site. Ask which sites are open, how many visits are expected, whether any steps can be done remotely, and whether travel costs or compensation are listed.
Who is behind this study?
This study is sponsored by Neumora Therapeutics, Inc., which appears to be a biotech company. If available, it can be useful to check the sponsor website, collaborators, investigator affiliation, and the official registry before deciding. HopeStage does not judge the quality of a sponsor or researcher, but helps you identify what to verify.
Can I still join this study?
The public registry lists this study as not currently recruiting. This page remains available for information. Check the official record for the latest status and explore other recruiting studies.
Explore other studies
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
